Novartis reported $3.63B in Cash and Equivalent for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Amgen AMGN:US $ 5203M 1325M
Astrazeneca AZN:US $ 4817M 945M
AstraZeneca AZN:LN 4817M 945M
Biogen BIIB:US $ 2646.6M 897.3M
Bristol Myers Squibb BMY:US $ 10750M 1619M
Canopy Growth Corp WEED:CN C$ 769.5M 464.17M
Catalent CTLT:US $ 786M 63M
Corcept Therapeutics CORT:US $ 35.35M 26.52M
Eli Lilly And LLY:US $ 2622.9M 163.7M
Endo International Ordinary Shares ENDP:US $ 1191.57M 221.58M
Gilead Sciences GILD:US $ 7000M 2704M
Glaxosmithkline GSK:US $ 6465M 4502M
GlaxoSmithKline GSK:LN 6465M 4502M
Horizon Pharma HZNP:US $ 1892.56M 249.43M
Lannett LCI:US $ 106.11M 7.47M
Novartis NOVN:VX SF 3625M 10227M
Pacira Pharmaceuticals PCRX:US $ 122.06M 104.69M
Perrigo Ordinary Shares PRGO:US $ 485.3M 1480.2M
Phibro Animal Health PAHC:US $ 70.75M 7.36M
Prestige Brands PBH:US $ 35.87M 8.68M
Supernus Pharmaceuticals SUPN:US $ 173.43M 57.71M
Teva Pharmaceutical Industries TEVA:US $ 2058M 117M
Valeant Pharmaceuticals VRX:CN $ 1249M 667M
Zoetis ZTS:US $ 2648M 484M